World Diabetes Day 2025: Turning Awareness into Actions Across Life Stages and Workplaces
Jointly launched by the International Diabetes Federation (IDF) and the World Health Organization (WHO) in 1991, the World Diabetes Day (WDD) aims to raise public awareness of diabetes, promote accurate diabetes education, and encourage individual and collective efforts to prevent, diagnose, and manage the disease. Annually observed on November 14, the date commemorates the birthday of Sir Frederick Banting, the Canadian surgeon who co-discovered insulin along with Charles Best in 1922, in honor of his ground-breaking contributions to diabetes research and treatment.
The WHO has set the theme for the 2025 edition of World Diabetes Day as “Diabetes across life stages,” emphasizing that everyone living with diabetes should have access to integrated care, supportive environments, and policies that promote health, dignity, and self-management. The campaign this year highlights the importance of a life-course approach to diabetes prevention, management, and overall well-being.
1 in 9: Alarming Global Trends and Hard Numbers
The latest research data published by the IDF present a stark picture: diabetes is no longer a marginal public-health challenge but a fast-escalating global epidemic. According to the 11th edition of IDF Diabetes Atlas released April 2025, an estimate of 589 million adults aged 20 to 79 are living with diabetes today, nearly one-ninth of the total population within this age range, and the number is projected to reach 853 million by 2050. Even worse, over 40% (about 252 million) of them remain unaware of their conditions, which could contribute to increased number and severity of complications and premature death. In 2024, diabetes caused about 3.4 million deaths, equivalent to one in every nine seconds.
Financially, diabetes exerts enormous strains on patients and their families, private and public payers, as well as governments and public health systems worldwide. Besides, severe clinical consequences of the disease, such as cardiovascular diseases, kidney failure, vision loss and amputations, could lead to increased direct medical expenses as well as indirect costs incurred from disabilities and reduced productivity. Back in 2007, the global diabetes-related health expenditure was approximately US $232 billion. However, in 2024, the figure surged to US $1.015 trillion, marking an alarming 338% increase over 17 years and being significantly faster than the prediction in the previous edition of the IDF Diabetes Atlas.
While the etiology of Type 1 diabetes remains poorly understood, it is widely believed to result from the combined effects of genetic predisposition, environmental factors, and autoimmune responses. In contrast, Type 2 diabetes, which accounts for the vast majority of cases globally, is largely preventable and treatable, yet its incidence is rapidly increasing globally. “Addressing the rising tide of diabetes will demand collaboration across multiple sectors and disciplines. Governments, the healthcare sector, education, technology and the private sectors all have a role to play. The consequences of ignoring or not paying sufficient attention to the diabetes challenge are too significant,” said Professor Peter Schwarz, IDF’s incumbent President. 000080
Prevention and Support Across Life Stages
The WHO coined the theme of WDD 2025 as “Diabetes across life stages,” highlighting the fact that diabetes can affect people at all ages, urging integrated prevention and care from childhood through older age and seeking empowerment of diabetics young and old alike. The life-course approach not only recognizes the various drivers of the disease, such as genetic and perinatal factors, obesogenic environments and sedentary patterns in daily life and workplace, but also stresses the need for age-appropriate policy and clinical strategies, including timely diagnosis and insulin access for children with type 1 diabetes, screening for gestational diabetes during pregnancy, preventive interventions targeting mid-life metabolic risks, as well as continuous and comprehensive care for older adults with multimorbidity.
The WHO has also defined explicit global coverage targets to be achieved by 2030, including diagnosing at least 80% of all diabetes cases, ensuring 80% of those diagnosed achieve optimal blood glucose and blood pressure control, and providing statin therapy to 60% of adults with diabetes of 40 years or older. For type 1 diabetes, WHO aims for universal and affordable access to insulin and blood glucose self-monitoring tools. These benchmarks serve as tangible policy goals for governments and healthcare systems, translating the life-course approach from an aspirational framework into measurable commitments that can drive accountability and long-term outcomes.
Employers and Employees Partnering for Diabetes Prevention and Management in the Workplace
Among the estimated 589 million diabetic adults worldwide, roughly 70% are of working age. Notably, many of them are facing multifaceted challenges in their working environments, including increased difficulty in glycemic management due to long working hours and high stress, stigma and discrimination against diabetics, declining work performance, and mental health issues. Also, many workplaces lack access to healthy food, opportunities for physical activity, and policies supporting diabetes screening and treatment, which may worsen the situation.
According to the official website of WDD 2025 by the IDF, this year’s edition focuses on diabetes and well-being, particularly in the workplace. The campaign calls on employers and employees everywhere to “Know more and do more for diabetes at work,” emphasizing the vital role that professional environments play in both prevention and day-to-day management.
Beyond clinical care, the focus extends to emotional and social well-being, advocating for inclusive, health-conscious workplaces where individuals living with diabetes can thrive without fear or isolation. The official campaign video released by the IDF on YouTube further amplifies this message. It illustrates real-world experiences of workers managing diabetes and highlights practical actions employers can adopt, such as flexible scheduling for glucose monitoring, access to healthy meals and snacks, and peer-support networks, demonstrating that workplace wellbeing is not ancillary, but central to tackling this global epidemic.
From Annual Single-day Observance to Continuous Change-making Actions
Overall, World Diabetes Day should be more than a single-day observance. It should act as a launchpad for measurable changes across policy, clinical practice and corporate governance, turning awareness into accountable action at national, workplace and community levels. Concrete, trackable measures include adoption of WHO’s 2030 global coverage targets, routine workplace screening with clear referral pathways, and corporate commitments on healthy food provision, protected time for physical activity and anti-discrimination policies.
As of 11 November 2025, the official WDD activities tracker lists 417 activities across 89 countries and territories this year, including online campaigns, community screening for diabetes (and its complications), workplace education sessions, workshops for healthcare professionals and policymakers, and symbolic “blue lighting” events, which involves illuminating iconic landmarks, public buildings, hospitals, or monuments in blue light—the official color of diabetes awareness. Individuals, employers, and civil-society organizations are encouraged to participate in, register, or organize WDD events through the official portal or their national diabetes associations.
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]








